Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1
The Journal of Immunology · 01.02.2024 · 212 (3) · 446-454
DOI: 10.4049/jimmunol.2300263 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.12.2023. Verfasst von Ruud H Wijdeven und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Histones, Ubiquitin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), EC | European Research Council (ERC).
Abstract (Originalsprache)
MHC class I (MHC-I) molecules are critical for CD8+ T cell responses to viral infections and malignant cells, and tumors can downregulate MHC-I expression to promote immune evasion. In this study, using a genome-wide CRISPR screen on a human melanoma cell line, we identified the polycomb repressive complex 1 (PRC1) subunit PCGF1 and the deubiquitinating enzyme BAP1 as opposite regulators of MHC-I transcription. PCGF1 facilitates deposition of ubiquitin at H2AK119 at the MHC-I promoters to silence MHC-I, whereas BAP1 removes this modification to restore MHC-I expression. PCGF1 is widely expressed in tumors and its depletion increased MHC-I expression in multiple tumor lines, including MHC-Ilow tumors. In cells characterized by poor MHC-I expression, PRC1 and PRC2 act in parallel to impinge low transcription. However, PCGF1 depletion was sufficient to increase MHC-I expression and restore T cell–mediated killing of the tumor cells. Taken together, our data provide an additional layer of regulation of MHC-I expression in tumors: epigenetic silencing by PRC1 subunit PCGF1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University Amsterdam, Amsterdam, the Netherlands.
- Alzheimer Center Amsterdam, Department of Neurology, Amsterdam UMC, Amsterdam, the Netherlands.
- Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Ruud H Wijdeven, Sietse J Luk, Tom A W Schoufour, Sabina Y van der Zanden, Marta Cabezuelo, Mirjam H M Heemskerk, Jacques Neefjes
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
- EC | European Research Council (ERC)
Zitieren
APA
Wijdeven, R. H., Luk, S. J., Schoufour, T. A. W., van der Zanden, S. Y., Cabezuelo, M., Heemskerk, M. H. M., & Neefjes, J. (2024). Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. The Journal of Immunology, 212(3), 446-454. https://doi.org/10.4049/jimmunol.2300263
Vancouver
Wijdeven RH, Luk SJ, Schoufour TAW, van der Zanden SY, Cabezuelo M, Heemskerk MHM, et al. Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. The Journal of Immunology. 2024;212(3):446-454. doi:10.4049/jimmunol.2300263
BibTeX
@article{Wijdeven2024,
author = {Wijdeven, Ruud H and Luk, Sietse J and Schoufour, Tom A W and van der Zanden, Sabina Y and Cabezuelo, Marta and Heemskerk, Mirjam H M and Neefjes, Jacques},
title = {Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {3},
pages = {446--454},
doi = {10.4049/jimmunol.2300263}
}
EUVIMED